Bir sonraki

Otomatik oynatma

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

3 Görünümler • 07/18/23
Pay
gömmek
administrator
administrator
Aboneler
0

Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma